CheckMyRecalls

Medicines & drugs recalls

909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.

Page 14 of 19

  1. Mylan-Cinacalcet: Affected lots exceed the established acceptable intake limit for N-nitroso-cinacalcet.Health CanadaProduct quality
  2. KABANA SKIN CARE recalls GreenScreen and 3 moreFDACGMP deviations
  3. Macleods Pharmaceuticals Ltd recalls Famciclovir TabletsFDAPresence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.
  4. Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
  5. Taro-Doxorubicin Liposomal: may contain particulate matterHealth CanadaProduct quality
  6. Twin Rivers Farm Ltd. recalls one lot of Surf Banana Split dried cannabis pre-rolls, one lot of Surf Layer Cake dried cannabis pre-rolls, and one lot of Surf Mac dried cannabis pre-rollsHealth CanadaLabelling and packaging
  7. Apo-Dutasteride 0.5 mg: Affected lot may contain undersized capsulesHealth CanadaProduct quality
  8. Tailstorm Health INC recalls KETAmine Hydrochloride Injection and 3 moreFDALack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
  9. Church & Dwight Inc recalls Orajel Baby and 2 moreFDAMicrobial Contamination of Non-Sterile Products: Fungal contamination of infant oral swabs.
  10. Orient Pharma Co., Ltd. Yunlin Plant recalls Pitavastatin TabletsFDAFailed Impurities/Degradation Specifications.
  11. The Harvard Drug Group LLC recalls Gabapentin CapsulesFDADefective container; blister packaging inadequately sealed.
  12. Granules Pharmaceuticals Inc. recalls Metoprolol Succinate Extended-Release TabletsFDAFailed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH)…
  13. Sandoz Inc recalls Cefazolin for Injection and 1 moreFDALabeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection,…
  14. AvKARE recalls Pitavastatin TabletsFDAFailed Impurity/Degradation Specifications
  15. NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tabletsHealth CanadaProduct safety
  16. Anesketin : Presence of particulate matter in the affected lotsHealth CanadaProduct quality
  17. PMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidateHealth CanadaProduct quality
  18. RIVA-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetineHealth CanadaProduct quality
  19. Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) recalls Semaglutide and 8 moreFDALack of Assurance of Sterility
  20. Fresenius Medical Care Holdings, Inc. recalls .9% Sodium Chloride InjectionFDALack of Assurance of Sterility
  21. Teva Pharmaceuticals USA, Inc recalls Metoclopramide TabletsFDAPresence of foreign tablets/capsules.
  22. Pfizer Inc. recalls DOBUTamine InjectionFDADiscoloration; discolored solution from cracked vials
  23. Apotex Corp. recalls Ketorolac Tromethamine Ophthalmic Solution and 2 moreFDALack of Assurance of Sterility
  24. Advanced Pharmaceutical Technology, Inc. recalls TESTO-200FDAMarketed Without an Approved NDA/ANDA
  25. B BRAUN MEDICAL INC recalls .9% Sodium Chloride Injection USPFDALack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.
  26. PMS-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetineHealth CanadaProduct quality
  27. Dr. Nutrition 360 Magnesium 200 mg capsule; Incorrect non-medicinal ingredient (Gelatin)Health CanadaProduct quality
  28. PRO-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetineHealth CanadaProduct quality
  29. Yi Li Xiao Capsule; Undeclared prescription drug (Tadalafil)Health CanadaProduct quality
  30. Aurobindo Pharma USA Inc recalls Acetaminophen TabletsFDACGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).
  31. Umary-USA.com recalls UNAVY ACIDO HIALURONICO and 1 moreFDAMarketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and…
  32. Eugia US LLC recalls Gentamicin InjectionFDAFailed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
  33. Gamunex solution; may cause allergic / hypersensitivity type reactionHealth CanadaAdverse reaction
  34. Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.Health CanadaProduct quality
  35. Teva-Piroxicam 10 mg capsule; Out of specification (Dissolution)Health CanadaProduct quality
  36. SAINI TRADE INC recalls ELECTRO BUZZ and 4 moreFDAMarketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared chloropretadalafil,…
  37. Alembic Pharmaceuticals Limited recalls Celecoxib CapsulesFDAPresence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule
  38. AvKARE recalls Chlorthalidone TabletsFDAFailed Dissolution Specifications
  39. Glenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin TabletsFDAFailed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time…
  40. AvKARE recalls Celecoxib CapsulesFDAPresence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg…
  41. Ascend Laboratories, LLC recalls Cephalexin for Oral SuspensionFDAFailed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of…
  42. Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules 1 gramFDAFailed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation…
  43. Macleods Pharmaceuticals Ltd recalls Levothyroxine Sodium TabletsFDAPresence of a foreign substance: black hair found embedded in tablet.
  44. Amneal Pharmaceuticals, LLC recalls Sulfamethoxazole and Trimethoprim TabletsFDAMicrobial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
  45. Weiteling tablet; Missing medical ingredient Bletilla striata & incorrect expiry dateHealth CanadaProduct quality
  46. JuHong TanKe JianGao liquid; missing medicinal ingredient "Glycyrrhiza uralensis" on labelHealth CanadaProduct quality
  47. Kimmtrak Solution; Out of specification (in-vitro potency assay)Health CanadaProduct quality
  48. Amerisource Health Services LLC recalls Indomethacin Extended-Release CapsulesFDACGMP deviations
  49. Apotex Corp. recalls Lacosamide Oral SolutionFDADefective Container: This recall is being initiated due to a leaking unit stored horizontally.
  50. Consumer Product Partners, LLC recalls Spectrum Advanced Gel Hand SanitizerFDASubpotent product: Product has cloudy appearance and tested below assay label claim for 70% Ethyl Alcohol